Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials (Q33315300)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials |
scientific article |
Statements
1 reference
11 references
13 March 2019
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials (English)
1 reference
9 references
13 March 2019
9 references
13 March 2019
C Salliot
1 reference
M Dougados
1 reference
L Gossec
1 reference
18 January 2008
1 reference
1 January 2009
11 references
13 March 2019
23 March 2019
17 June 2019
30 June 2019
1 August 2019
20 November 2019
27 November 2019
26 September 2020
14 November 2020
1 February 2021
28 October 2022
12 references
13 March 2019
23 March 2019
17 June 2019
30 June 2019
1 August 2019
20 November 2019
27 November 2019
26 September 2020
14 November 2020
1 February 2021
28 October 2022
11 references
13 March 2019
23 March 2019
17 June 2019
30 June 2019
1 August 2019
20 November 2019
27 November 2019
26 September 2020
14 November 2020
1 February 2021
28 October 2022
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference